tech
The Model Is the Easy Part
Plus: Plus: Codex folds into ChatGPT, and why the next drug giant won't be an AI company
TL;DR
- Defining measurable goals is crucial for efficient AI adoption and value creation.
- Companies can generate revenue by selling anonymized gameplay or other operational data to AI labs.
- Selling data to AI labs can help improve AI models, but companies must protect their IP.
- In drug discovery, AI is a small part of a long process, and expertise in medicinal chemistry and toxicology remains critical.
- The future of drug development may see pharma companies integrating AI rather than AI companies dominating pharma.